Defining the role of glymphatic dysfunction in the development of Alzheimer’s disease

Dates and Times

Start: 2/27/2026 8:00 AM
End: 2/27/2026 9:00 AM

Objectives

1. Describe the biology of the glymphatic system, as it was initially described and characterized in rodent studies.
2. Describe the corollary data that support the contribution that glymphatic dysfunction makes towards the development of Alzheimer’s disease.
3. Describe the potential utility of targeting glymphatic dysfunction in the prevention and treatment of Alzheimer’s disease.

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.